Muhunthan Thillai MD, co-founder and CEO, Qureight, commented: “Rebecca’s experience, expertise and people-centric leadership ...

Lundbeck A/S has announced encouraging new data from the intravenous part of its phase 2b PROCEED trial, showing that investigational migraine prevention treatment bocunebart achieved its primary ...

The European Life Sciences Coalition has been launched in Brussels with the aim of strengthening Europe’s life sciences and ...

Serac Healthcare has received fast track designation from the US Food and Drug Administration for 99mTc‑maraciclatide, a SPECT‑CT imaging agent intended for the visualisation of inflammation in ...

Bioxytran has reported positive results from its completed phase 2 trial of ProLectin‑M, showing rapid and sustained viral clearance in subjects with laboratory‑confirmed acute viral infection. The ...

THX Pharma and Biocodex have entered a strategic licensing agreement covering three rare diseases, with Biocodex acquiring rights to develop and commercialise two drug candidates across multiple ...

Re:Cognition Health, a global leader in brain and memory health research, and Cera – Europe’s largest digital‑first home healthcare provider – have announced a new collaboration designed to expand ...

AstraZeneca has received a positive recommendation from the National Institute for Health and Care Excellence for durvalumab, ...